-
1
-
-
0037921348
-
The neuroleptic-nonresponsive patient: An introduction
-
Angrist B, Schulz SC, eds. Washington, DC: American Psychiatric Press
-
Angrist B, Schulz SC. The neuroleptic-nonresponsive patient: an introduction. In: Angrist B, Schulz SC, eds. The Neuroleptic-Nonresponsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press; 1990: xvii-xxviii
-
(1990)
The Neuroleptic-nonresponsive Patient: Characterization and Treatment
-
-
Angrist, B.1
Schulz, S.C.2
-
3
-
-
0027178496
-
Psychopharmacologic treatment of schizophrenia
-
Kane JM, Marder SR. Psychopharmacologic treatment of schizophrenia. Schizophr Bull 1993;19:287-302
-
(1993)
Schizophr Bull
, vol.19
, pp. 287-302
-
-
Kane, J.M.1
Marder, S.R.2
-
4
-
-
0011560044
-
Nonresponders to neuroleptics: A distinct subtype
-
Schulz SC, Tamminga CA, eds. New York, NY: Oxford University Press
-
Schulz SC, Conley RR, Kahn EM, et al. Nonresponders to neuroleptics: a distinct subtype. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:341-350
-
(1989)
Schizophrenia: Scientific Progress
, pp. 341-350
-
-
Schulz, S.C.1
Conley, R.R.2
Kahn, E.M.3
-
5
-
-
0025978419
-
National institute of mental health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome
-
Breier AF, Schreiber JL, Dyer J, et al. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-246
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 239-246
-
-
Breier, A.F.1
Schreiber, J.L.2
Dyer, J.3
-
6
-
-
0026040246
-
Neuroleptics and the natural course of schizophrenia
-
Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-351
-
(1991)
Schizophr Bull
, vol.17
, pp. 325-351
-
-
Wyatt, R.J.1
-
7
-
-
0017278835
-
Recent developments in the drug treatment of schizophrenia
-
Davis JM. Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 1976;133:208-214
-
(1976)
Am J Psychiatry
, vol.133
, pp. 208-214
-
-
Davis, J.M.1
-
8
-
-
0016731931
-
Very high dosage versus standard dosage fluphenazine in schizophrenia: A double-blind study of non-chronic treatment-refractory patients
-
Quitkin FM, Rifkin A, Klein DF. Very high dosage versus standard dosage fluphenazine in schizophrenia: a double-blind study of non-chronic treatment-refractory patients. Arch Gen Psychiatry 1975;32:1276-1281
-
(1975)
Arch Gen Psychiatry
, vol.32
, pp. 1276-1281
-
-
Quitkin, F.M.1
Rifkin, A.2
Klein, D.F.3
-
10
-
-
0019430196
-
Rapid treatment of acute psychotic symptoms with high-and low-dose haloperidol: Behavioral considerations
-
Neborsky R, Janowsky D, Munson E, et al. Rapid treatment of acute psychotic symptoms with high-and low-dose haloperidol: behavioral considerations. Arch Gen Psychiatry 1981;38:195-199
-
(1981)
Arch Gen Psychiatry
, vol.38
, pp. 195-199
-
-
Neborsky, R.1
Janowsky, D.2
Munson, E.3
-
11
-
-
0023184229
-
Low and conventional-dose maintenance therapy with fluphenazine decanoate
-
Marder SR, Van Putten T, Mintz J, et al. Low and conventional-dose maintenance therapy with fluphenazine decanoate. Arch Gen Psychiatry 1987; 44:518-521
-
(1987)
Arch Gen Psychiatry
, vol.44
, pp. 518-521
-
-
Marder, S.R.1
Van Putten, T.2
Mintz, J.3
-
12
-
-
0344017758
-
Benzodiazepine augmentation of neuroleptics
-
Angrist B, Schulz SC, eds. Washington, DC: American Psychiatric Press
-
Wolkowitz OM, Rapaport MH, Pickar D. Benzodiazepine augmentation of neuroleptics. In: Angrist B, Schulz SC, eds. The Neuroleptic-Nonresponsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press; 1990:87-108
-
(1990)
The Neuroleptic-nonresponsive Patient: Characterization and Treatment
, pp. 87-108
-
-
Wolkowitz, O.M.1
Rapaport, M.H.2
Pickar, D.3
-
13
-
-
0018372191
-
Combination of lithium carbonate and haloperidol in schizoaffective disorder: A controlled study
-
Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and haloperidol in schizoaffective disorder: a controlled study. Arch Gen Psychiatry 1979;36:327-333
-
(1979)
Arch Gen Psychiatry
, vol.36
, pp. 327-333
-
-
Biederman, J.1
Lerner, Y.2
Belmaker, R.H.3
-
14
-
-
0019460191
-
Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients
-
Carman JS, Bigelow LB, Wyatt RJ. Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 1981;42:124-128
-
(1981)
J Clin Psychiatry
, vol.42
, pp. 124-128
-
-
Carman, J.S.1
Bigelow, L.B.2
Wyatt, R.J.3
-
16
-
-
0016830149
-
A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients
-
Small JG, Kellams JJ, Milstein V, et al. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. Am J Psychiatry 1975;132:1315-1317
-
(1975)
Am J Psychiatry
, vol.132
, pp. 1315-1317
-
-
Small, J.G.1
Kellams, J.J.2
Milstein, V.3
-
17
-
-
85077805398
-
Presynaptic modulators of dopamine synthesis in the treatment of chronic schizophrenia
-
Angrist B, Schulz SC, eds. Washington, DC: American Psychiatric Press
-
Berlant JL. Presynaptic modulators of dopamine synthesis in the treatment of chronic schizophrenia. In: Angrist B, Schulz SC, eds. The Neuroleptic-Nonresponsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press; 1990:137-152
-
(1990)
The Neuroleptic-nonresponsive Patient: Characterization and Treatment
, pp. 137-152
-
-
Berlant, J.L.1
-
18
-
-
0017808152
-
Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients
-
Bacher NM, Lewis HA. Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients. Am J Psychiatry 1978; 135:488-489
-
(1978)
Am J Psychiatry
, vol.135
, pp. 488-489
-
-
Bacher, N.M.1
Lewis, H.A.2
-
19
-
-
0018971860
-
Propranolol in chronic schizophrenia: A controlled study in neuroleptic treated patients
-
Lindstrom L, Persson E. Propranolol in chronic schizophrenia: a controlled study in neuroleptic treated patients. Br J Psychiatry 1980;137: 125-130
-
(1980)
Br J Psychiatry
, vol.137
, pp. 125-130
-
-
Lindstrom, L.1
Persson, E.2
-
20
-
-
0020549843
-
Propranolol in schizophrenia: A double-blind, placebo-controlled trial of propranolol as an adjunct to neuroleptic medication
-
Pugh C, Steinert J, Priest R. Propranolol in schizophrenia: a double-blind, placebo-controlled trial of propranolol as an adjunct to neuroleptic medication. Br J Psychiatry 1983;143:151-155
-
(1983)
Br J Psychiatry
, vol.143
, pp. 151-155
-
-
Pugh, C.1
Steinert, J.2
Priest, R.3
-
21
-
-
0017697831
-
Propranolol as an adjunct to the treatment of schizophrenia
-
Yorkston N, Zaki SA, Pitcher DR, et al. Propranolol as an adjunct to the treatment of schizophrenia. Lancet 1977;2:575-578
-
(1977)
Lancet
, vol.2
, pp. 575-578
-
-
Yorkston, N.1
Zaki, S.A.2
Pitcher, D.R.3
-
22
-
-
0023621979
-
Lorazepam/haloperidol combination therapy in schizophrenia: A double-blind study
-
Altamura AC, Mauri MC, Mantero M, et al. Lorazepam/haloperidol combination therapy in schizophrenia: a double-blind study. Acta Psychiatr Scand 1987;76:702-706
-
(1987)
Acta Psychiatr Scand
, vol.76
, pp. 702-706
-
-
Altamura, A.C.1
Mauri, M.C.2
Mantero, M.3
-
23
-
-
0016815596
-
Anxiety in schizophrenia: The responses to chlordiazepoxide in an intensive design study
-
Kellner R, Wilson RM, Mudawer MD, et al. Anxiety in schizophrenia: the responses to chlordiazepoxide in an intensive design study. Arch Gen Psychiatry 1975;32:1246-1254
-
(1975)
Arch Gen Psychiatry
, vol.32
, pp. 1246-1254
-
-
Kellner, R.1
Wilson, R.M.2
Mudawer, M.D.3
-
24
-
-
0020040551
-
Carbamazepine in treatment of violent schizophrenics
-
Hakola HPA, Lauluma VA. Carbamazepine in treatment of violent schizophrenics [letter]. Lancet 1982;1:1358
-
(1982)
Lancet
, vol.1
, pp. 1358
-
-
Hakola, H.P.A.1
Lauluma, V.A.2
-
25
-
-
0021249353
-
Carbamazepine and neuroleptics in the treatment of schizophrenia
-
Luchins B. Carbamazepine and neuroleptics in the treatment of schizophrenia. Psychopharmacol Bull 1984;20:569-571
-
(1984)
Psychopharmacol Bull
, vol.20
, pp. 569-571
-
-
Luchins, B.1
-
26
-
-
0020512131
-
Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities
-
Neppe VM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry 1983;44:326-331
-
(1983)
J Clin Psychiatry
, vol.44
, pp. 326-331
-
-
Neppe, V.M.1
-
27
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
-
Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
-
28
-
-
0024841558
-
Acute treatment response and short term outcome in schizophrenia: First results of the NIMH treatment strategies in schizophrenia study. Treatment strategies in schizophrenia collaborative study group
-
Schooler NR, Keith SJ, Severe JB, et al. Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group. Psychopharmacol Bull 1989;5:331-335
-
(1989)
Psychopharmacol Bull
, vol.5
, pp. 331-335
-
-
Schooler, N.R.1
Keith, S.J.2
Severe, J.B.3
-
29
-
-
0025255494
-
Change in haloperidol level due to carbamazepine: A complicating medication for schizophrenia
-
Kahn EM, Schulz SC, Perel JM, et al. Change in haloperidol level due to carbamazepine: a complicating medication for schizophrenia. J Clin Psychopharmacol 1990;10:54-57
-
(1990)
J Clin Psychopharmacol
, vol.10
, pp. 54-57
-
-
Kahn, E.M.1
Schulz, S.C.2
Perel, J.M.3
-
30
-
-
0017044625
-
Adverse reactions in treatment with lithium carbonate and haloperidol
-
Baastrup PC, Hollnagel P, Sorensen R, et al. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 1976;236:2645-2646
-
(1976)
JAMA
, vol.236
, pp. 2645-2646
-
-
Baastrup, P.C.1
Hollnagel, P.2
Sorensen, R.3
-
31
-
-
0019994882
-
Neurotoxicity in patients with schizophrenia during lithium therapy
-
Prakash R, Kelwala S, Ban TA. Neurotoxicity in patients with schizophrenia during lithium therapy. Compr Psychiatry 1982;23:271-273
-
(1982)
Compr Psychiatry
, vol.23
, pp. 271-273
-
-
Prakash, R.1
Kelwala, S.2
Ban, T.A.3
-
32
-
-
0020371960
-
Neurotoxicity with combined administration of lithium and a neuroleptic
-
Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1982;23:567-571
-
(1982)
Compr Psychiatry
, vol.23
, pp. 567-571
-
-
Prakash, R.1
Kelwala, S.2
Ban, T.A.3
-
33
-
-
0023924694
-
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: Preliminary results
-
Wolkowitz OM, Breier A, Doran A, et al. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 1988;45:664-671
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 664-671
-
-
Wolkowitz, O.M.1
Breier, A.2
Doran, A.3
-
35
-
-
0021363587
-
Impact of lithium therapy on core psychotic symptoms of schizophrenia
-
Zemlan FP, Hirschowitz J, Sautter FJ, et al. Impact of lithium therapy on core psychotic symptoms of schizophrenia. Br J Psychiatry 1984;144: 64-69
-
(1984)
Br J Psychiatry
, vol.144
, pp. 64-69
-
-
Zemlan, F.P.1
Hirschowitz, J.2
Sautter, F.J.3
-
36
-
-
0015386388
-
A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives: Report of the veterans administration and national institute of mental health collaborative study group
-
Prien RF, Caffey EM Jr, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives: report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1972;27:182-189
-
(1972)
Arch Gen Psychiatry
, vol.27
, pp. 182-189
-
-
Prien, R.F.1
Caffey E.M., Jr.2
Klett, C.J.3
-
37
-
-
0015135942
-
A controlled study of lithium vs chlorpromazine in acute schizophrenics
-
Shopsin B, Kim SS, Gershon S. A controlled study of lithium vs chlorpromazine in acute schizophrenics. Br J Psychiatry 1971;119:435-440
-
(1971)
Br J Psychiatry
, vol.119
, pp. 435-440
-
-
Shopsin, B.1
Kim, S.S.2
Gershon, S.3
-
38
-
-
0004085199
-
-
New York, NY: Biometric Research, New York State Psychiatric Institute
-
Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R Psychotic Disorders Version (SCID-PD, 7/1/85); New York, NY: Biometric Research, New York State Psychiatric Institute; 1985
-
(1985)
Structured Clinical Interview for DSM-III-R Psychotic Disorders Version (SCID-PD, 7/1/85)
-
-
Spitzer, R.L.1
Williams, J.B.W.2
Gibbon, M.3
-
39
-
-
0000503515
-
The brief psychiatric rating scale
-
Overall JE, Gorman DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
-
(1962)
Psychol Rep
, vol.10
, pp. 799-812
-
-
Overall, J.E.1
Gorman, D.R.2
-
41
-
-
0003412410
-
-
US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health
-
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
-
(1976)
ECDEU Assessment Manual for Psychopharmacology
, pp. 218-222
-
-
Guy, W.1
-
42
-
-
0014723449
-
A rating scale for extrapyramidal side effects
-
Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;45(suppl 212):11-19
-
(1970)
Acta Psychiatr Scand Suppl
, vol.45
, Issue.212 SUPPL.
, pp. 11-19
-
-
Simpson, G.M.1
Angus, J.W.S.2
-
43
-
-
0022481698
-
SAFTEE: A technique for the systematic assessment of side effects in clinical trials
-
Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986;22: 343-381
-
(1986)
Psychopharmacol Bull
, vol.22
, pp. 343-381
-
-
Levine, J.1
Schooler, N.R.2
-
46
-
-
0027152241
-
Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial
-
Wilson WH. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology (Berl) 1993;111: 359-366
-
(1993)
Psychopharmacology (Berl)
, vol.111
, pp. 359-366
-
-
Wilson, W.H.1
-
47
-
-
0025768391
-
Lithium carbonate in chronic schizophrenia: A brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients
-
Collins PJ, Larkin EP, Shubsachs APW. Lithium carbonate in chronic schizophrenia: a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatr Scand 1991; 84:150-154
-
(1991)
Acta Psychiatr Scand
, vol.84
, pp. 150-154
-
-
Collins, P.J.1
Larkin, E.P.2
Shubsachs, A.P.W.3
|